Live feed
Filing
SCHEDULE 13D
SCHEDULE 13D0001214659-25-003297·CARGO Therapeutics, Inc.
Schedule 13D ownership disclosure
N/A
Common Stock, par value $0.001 per share · CUSIP: 14179K101
Event date: 2025-02-13
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- TANG CAPITAL MANAGEMENT, LLCReported CIK 0001232621
Shares: 2,729,288.00 · Class: 5.9%
- KEVIN TANGReported CIK 0001178579
Shares: 2,729,288.00 · Class: 5.9%
- TANG CAPITAL PARTNERS, LPReported CIK 0001191935
Shares: 1,534,946.00 · Class: 3.3%
- TANG CAPITAL PARTNERS INTERNATIONAL, LP
Shares: 1,194,342.00 · Class: 2.6%
- TANG CAPITAL PARTNERS III, INC
Shares: 0.00 · Class: 0%
- TANG CAPITAL PARTNERS IV, INC
Shares: 0.00 · Class: 0%
- CONCENTRA BIOSCIENCES, LLCReported CIK 0001970065
Shares: 0.00 · Class: 0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001214659-25-003297
- Form type
- SCHEDULE 13D
- Filer
- CARGO Therapeutics, Inc.
- CIK
- CIK 1966494
- Filed
- Feb 21, 2025
- Reporting period
- Feb 13, 2025
- Description
- Schedule 13D beneficial ownership